ECMOHO Competitors

Amazon.com (NASDAQ:AMZN) and ECMOHO (NASDAQ:MOHO) are both retail/wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

Risk & Volatility

Amazon.com has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, ECMOHO has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.

Insider and Institutional Ownership

56.4% of Amazon.com shares are owned by institutional investors. Comparatively, 0.4% of ECMOHO shares are owned by institutional investors. 16.1% of Amazon.com shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for Amazon.com and ECMOHO, as reported by MarketBeat.com.

Amazon.com currently has a consensus target price of $4,180.5435, suggesting a potential upside of 29.71%. Given Amazon.com's higher probable upside, equities research analysts plainly believe Amazon.com is more favorable than ECMOHO.

Valuation & Earnings

This table compares Amazon.com and ECMOHO's top-line revenue, earnings per share (EPS) and valuation.

Amazon.com has higher revenue and earnings than ECMOHO.

Profitability

This table compares Amazon.com and ECMOHO's net margins, return on equity and return on assets.

Summary

Amazon.com beats ECMOHO on 11 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Wayfair (NYSE:W) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Wayfair has a beta of 3.43, indicating that its stock price is 243% more volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 81.3% of Wayfair shares are owned by institutional investors. 30.9% of Wayfair shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and Wayfair, as provided by MarketBeat.

Wayfair has a consensus target price of $317.4286, suggesting a potential upside of 5.81%. Given Wayfair's higher probable upside, analysts clearly believe Wayfair is more favorable than ECMOHO.

Valuation and Earnings

This table compares ECMOHO and Wayfair's gross revenue, earnings per share and valuation.

ECMOHO has higher earnings, but lower revenue than Wayfair.

Profitability

This table compares ECMOHO and Wayfair's net margins, return on equity and return on assets.

Summary

Wayfair beats ECMOHO on 8 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Chewy (NYSE:CHWY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Chewy has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 97.6% of Chewy shares are owned by institutional investors. 0.4% of Chewy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and Chewy, as provided by MarketBeat.

Chewy has a consensus target price of $92.5263, suggesting a potential upside of 36.57%. Given Chewy's higher probable upside, analysts clearly believe Chewy is more favorable than ECMOHO.

Valuation and Earnings

This table compares ECMOHO and Chewy's gross revenue, earnings per share and valuation.

ECMOHO has higher earnings, but lower revenue than Chewy.

Profitability

This table compares ECMOHO and Chewy's net margins, return on equity and return on assets.

Summary

Chewy beats ECMOHO on 8 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and CDW (NASDAQ:CDW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, CDW has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 91.4% of CDW shares are owned by institutional investors. 1.3% of CDW shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and CDW, as provided by MarketBeat.

CDW has a consensus target price of $172.8571, suggesting a potential upside of 2.01%. Given CDW's higher probable upside, analysts clearly believe CDW is more favorable than ECMOHO.

Valuation and Earnings

This table compares ECMOHO and CDW's gross revenue, earnings per share and valuation.

CDW has higher revenue and earnings than ECMOHO.

Profitability

This table compares ECMOHO and CDW's net margins, return on equity and return on assets.

Summary

CDW beats ECMOHO on 11 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Vipshop (NYSE:VIPS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Vipshop has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Valuation and Earnings

This table compares ECMOHO and Vipshop's gross revenue, earnings per share and valuation.

Vipshop has higher revenue and earnings than ECMOHO.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and Vipshop, as provided by MarketBeat.

Vipshop has a consensus target price of $30.1250, suggesting a potential upside of 19.35%. Given Vipshop's higher probable upside, analysts clearly believe Vipshop is more favorable than ECMOHO.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 49.4% of Vipshop shares are owned by institutional investors. 29.5% of Vipshop shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares ECMOHO and Vipshop's net margins, return on equity and return on assets.

Summary

Vipshop beats ECMOHO on 11 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Ozon (NASDAQ:OZON) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

Valuation & Earnings

This table compares ECMOHO and Ozon's gross revenue, earnings per share and valuation.

ECMOHO has higher revenue and earnings than Ozon.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for ECMOHO and Ozon, as provided by MarketBeat.com.

Ozon has a consensus price target of $51.00, suggesting a potential downside of 8.65%. Given Ozon's higher possible upside, analysts plainly believe Ozon is more favorable than ECMOHO.

Insider & Institutional Ownership

0.4% of ECMOHO shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares ECMOHO and Ozon's net margins, return on equity and return on assets.

Summary

Ozon beats ECMOHO on 5 of the 7 factors compared between the two stocks.